BACKGROUND Pancreatic adenocarcinoma is an aggressive malignancy with a high propensity to metastasize.Esophageal metastasis manifesting as dysphagia is rarely reported in the literature and has not to our knowledge b...BACKGROUND Pancreatic adenocarcinoma is an aggressive malignancy with a high propensity to metastasize.Esophageal metastasis manifesting as dysphagia is rarely reported in the literature and has not to our knowledge been reported prior to the appearance of the primary disease.CASE SUMMARY A patient presented with progressive dysphagia to solids and a persistent earache.Computed tomography of the neck and chest revealed a 3.0 cm×1.8 cm heterogeneous mass originating from the upper third of the esophagus,necrotic cervical and supraclavicular lymphadenopathy,and bilateral pulmonary nodules.She underwent a core needle biopsy of a right cervical node,which suggested a well-differentiated adenocarcinoma of unknown primary.She had an upper endoscopy with biopsy of the esophageal mass suggestive of a welldifferentiated adenocarcinoma.Positron emission tomography imaging revealed increased uptake in the esophageal mass,cervical,and mediastinal lymph nodes.She was started on folinic acid,fluorouracil,and oxaliplatin.Prior to initiation of cycle 8,the patient was found to have a pancreatic body mass that was not present on prior radiographic imaging,confirmed by endoscopic ultrasonography and biopsy to be pancreatic adenocarcinoma.CA19-9 was>10000 U/m L,suggesting a primary pancreaticobiliary origin.CONCLUSION Esophageal metastasis diagnosed before primary pancreatic adenocarcinoma is rare.This case highlights the profound metastatic potential of pancreatic adenocarcinoma.展开更多
文摘BACKGROUND Pancreatic adenocarcinoma is an aggressive malignancy with a high propensity to metastasize.Esophageal metastasis manifesting as dysphagia is rarely reported in the literature and has not to our knowledge been reported prior to the appearance of the primary disease.CASE SUMMARY A patient presented with progressive dysphagia to solids and a persistent earache.Computed tomography of the neck and chest revealed a 3.0 cm×1.8 cm heterogeneous mass originating from the upper third of the esophagus,necrotic cervical and supraclavicular lymphadenopathy,and bilateral pulmonary nodules.She underwent a core needle biopsy of a right cervical node,which suggested a well-differentiated adenocarcinoma of unknown primary.She had an upper endoscopy with biopsy of the esophageal mass suggestive of a welldifferentiated adenocarcinoma.Positron emission tomography imaging revealed increased uptake in the esophageal mass,cervical,and mediastinal lymph nodes.She was started on folinic acid,fluorouracil,and oxaliplatin.Prior to initiation of cycle 8,the patient was found to have a pancreatic body mass that was not present on prior radiographic imaging,confirmed by endoscopic ultrasonography and biopsy to be pancreatic adenocarcinoma.CA19-9 was>10000 U/m L,suggesting a primary pancreaticobiliary origin.CONCLUSION Esophageal metastasis diagnosed before primary pancreatic adenocarcinoma is rare.This case highlights the profound metastatic potential of pancreatic adenocarcinoma.
